{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:50:20Z","timestamp":1791985820791,"version":"4.4.0"},"reference-count":15,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2024,2,20]]},"DOI":"10.1167\/tvst.13.2.13","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:30:55Z","timestamp":1708446655000},"page":"13","source":"Crossref","is-referenced-by-count":21,"title":["Chorioretinal Atrophy Growth After Voretigene Neparvovec Retinotopically Is Connected to Retinal Functional Rescue"],"prefix":"10.1167","volume":"13","author":[{"given":"Krunoslav","family":"Stingl","sequence":"first","affiliation":[{"name":"University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Eye Diseases, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kempf","sequence":"additional","affiliation":[{"name":"University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Eye Diseases, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronja","family":"Jung","sequence":"additional","affiliation":[{"name":"University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Stingl","sequence":"additional","affiliation":[{"name":"University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Eye Diseases, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood\u2013onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat Genet"},{"issue":"10097","key":"bib3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"bib4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bjophthalmol-2020-318286","article-title":"Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec","volume":"106","author":"Stingl","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"bib5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ophtha.2023.02.015","article-title":"Full-field scotopic threshold improvement after voretigene neparvovec-rzyl treatment correlates with chorioretinal atrophy","volume":"130","author":"Stingl","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"bib6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated Leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"bib7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"Reichel","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"bib8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated Leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"101115","DOI":"10.1016\/j.preteyeres.2022.101115","article-title":"Therapy with voretigene neparvovec. How to measure success?","volume":"92","author":"Stingl","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib10","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1111\/aos.v100.3","article-title":"Short term morphological rescue of the fovea after gene therapy with voretigene neparvovec","volume":"100","author":"Kort\u00fcm","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"bib11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000510888","article-title":"Clinical protocols for the evaluation of rod function","volume":"244","author":"Stingl","year":"2021","journal-title":"Ophthalmologica"},{"issue":"11","key":"bib12","doi-asserted-by":"publisher","first-page":"e2038","DOI":"10.1002\/mgg3.v10.11","article-title":"Chorioretinal atrophy following voretigene neparvovec despite the presence of fundus autofluorescence","volume":"10","author":"Kolesnikova","year":"2022","journal-title":"Mol Genet Genomic Med"},{"issue":"6","key":"bib13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bjophthalmol-2020-318286","article-title":"Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec","volume":"106","author":"Stingl","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"bib14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ophtha.2022.06.018","article-title":"Inflammation after voretigene neparvovec administration in patients with RPE65-related retinal dystrophy","volume":"129","author":"Kessel","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"bib15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bjo-2022-321488","article-title":"Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy","volume":"107","author":"Lopez","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"bib2","first-page":"4293","article-title":"Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration","volume-title":"Invest Ophthalmol Vis Sci.","author":"Thompson","year":"2000"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2793381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:30:59Z","timestamp":1708446659000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2793381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.13.2.13","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}